Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Privacy Perils: Beware of Disabling Pop-up Blockers

Firm Publication

Publications

February 19, 2016

Pesky pop-up ads are an annoyance everyone who searches the internet faces at some point. To avoid these irritating and often unwanted messages, users turn to ad-blockers for help; however, a growing number of websites are forcing visitors to turn off their ad-blockers to gain access to the site's content. While you may think that doing so would be harmless on a trusted site, think twice, weigh the risks and be careful. While a site may control its own content, it doesn't necessarily control or police its advertisers' content. 

Consider an issue that arose with the Forbes website. Upon visiting Forbes' site to read its "30 Under 30" list, a security expert had to disable his ad-blocker to view the article. Given the reputation of the Forbes brand, one might not hesitate to turn off such a blocker, and this expert did just that. However, not only did doing so allow him to read the article, it also infected his computer with malware that could impair its operation, and steal private data such as banking information and passwords. 

While computer threats are an unfortunate reality, there are several ways to mitigate your risk. Security software is a users' most important defensive tool, but you must keep that software updated. Adjust your web browser's security settings to minimize unwelcome intrusions. Finally, trust your instincts and be careful what you click.

Privacy Perils imageCheck out our series, Privacy Perils, to learn what steps you can take to guard your personal and company data. For more information about this topic and other cyber security concerns, please contact Bob Brewer, Tony McFarland, Elizabeth Warren or a member of our Privacy & Data Security team.

 


Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.